Últimas noticias sobre Zenvia (NASDAQ:ZENV) Bolsa

Zenvia

Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

MVIS

ONDS

ZENV

Ondas Holdings, Microvision y Zenvia muestran niveles de RSI por encima de 70, señalando posibles riesgos de sobrecompra.

Tres acciones tecnológicas sobrecompradas que podrían estar advirtiendo a los inversores

Zenvia Inc

On Tuesday, Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>)&nbsp;announced it has acquired&nbsp;Halfspace, a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44102381/accenture-acquires-halfspace-to-bolster-ai-capabilities-in-the-nordic-region" rel="noreferrer noopener">Denmark-based AI company</a>&nbsp;that helps organizations leverage and scale AI to make better,&nbsp;more informed decisions faster. The financial terms of the deal remain undisclosed.
The acquisition enhances Accenture&#8217;s AI capabilities and talent in Nordic and European regions.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44083704/verizon-and-accenture-partner-to-expand-cybersecurity-services-and-strengthen-business-protections" rel="noreferrer noopener">Verizon and Accenture Partner to Expand Cybersecurity Services and Strengthen Business Protections</a>
With the addition of Halfspace, Accenture will extend the Center for Advanced AI into the Nordics, focused on helping clients capture and create value from AI.
Founded in 2015, Halfspace develops AI and generative AI solutions and products that drive value creation by streamlining complex business workflows and uses advanced analytics and data science to transform data into actionable insights.
Halfspace adds nearly 80 highly qualified AI practitioners to Accenture&#8217;s Nordic AI practice. The company also has strong ecosystem relationships with leading AI platform companies, including Databricks, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Accenture also snapped up Altus Consulting to further enhance its strategic advisory and delivery services for insurance, investments, and other financial services businesses <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44102865/accenture-acquires-altus-consulting-to-strengthen-capabilities-for-insurance-and-investments-clien" rel="noreferrer noopener">across the UK</a>. The financial terms of this deal remain undisclosed.
Founded in 2005, Altus Consulting has developed advisory services with deep knowledge of the operating models, data, and platforms that power financial services organizations.
Altus Consulting&#8217;s highly skilled team will join Accenture&#8217;s&nbsp;Insurance practice&nbsp;in the UK, bringing expertise in areas including distribution, risk and regulation, operating models, data, and technology.
Accenture&#8217;s total cash balance on November 30, 2024, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42572094/accenture-reports-first-quarter-fiscal-2025-results" rel="noreferrer noopener">was $8.3 billion</a>.
Accenture stock has been down over 10% in the last 12 months. At least <a target="_blank" href="https://www.benzinga.com/quote/ACN/analyst-ratings" rel="noreferrer noopener">two Wall Street firms</a>, Jefferies and Stifel, cut their price targets on the stock in 2025.
Accenture reported&nbsp;<a target="_blank" href="https://www.benzinga.com/24/12/42586612/accenture-delivers-q1-revenue-growth-bolstered-by-consulting-and-managed-services" rel="noreferrer noopener">first-quarter fiscal 2025</a> sales of $17.69 billion compared with the analyst consensus estimate of $17.12 billion, up 9%.&nbsp;
The adjusted EPS of $3.59 topped the&nbsp;analyst consensus estimate of $3.39. Accenture expects second-quarter revenues of $16.2 billion–$16.8 billion (versus&nbsp;consensus of $16.63 billion).
Price Action: ACN stock traded lower by 1.16% to $341.01 premarket at the last check on Tuesday.

Eurozone

MSFT

NVDA

Accenture M&A: Acquires AI Firm Halfspace, Altus Consulting In UK To Expand Advanced AI Solutions in Europe

Contracts

ICLR

Mural Health Technologies Enters Partnership With ICON To Utilize Mural Link For Trial Payments, Travel Support, And Communication Tools

Riot Produces 470 Bitcoin in February 2025
CASTLE ROCK, Colo., March 4, 2025 /PRNewswire/ -- Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) ("Riot" or "the Company"), an industry leader in vertically integrated Bitcoin ("BTC") mining, announces unaudited production and operations updates for February 2025.&nbsp;&nbsp;
Bitcoin Production and Operations Updates for February 2025
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="2" rowspan="1">Comparison (%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Metric</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">February 2025 1</td>
<td colspan="1" rowspan="1">January 2024 1</td>
<td colspan="1" rowspan="1">February 2024</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Month/Month</td>
<td colspan="1" rowspan="1">Year/Year</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bitcoin Produced</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">470</td>
<td colspan="1" rowspan="1">527</td>
<td colspan="1" rowspan="1">418</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-11&nbsp;%</td>
<td colspan="1" rowspan="1">12&nbsp;%</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Average Bitcoin Produced per Day</td>
<td colspan="1" rowspan="1">16.8</td>
<td colspan="1" rowspan="1">17.0</td>
<td colspan="1" rowspan="1">14.4</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-1&nbsp;%</td>
<td colspan="1" rowspan="1">16&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bitcoin Held 2</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">18,692</td>
<td colspan="1" rowspan="1">18,221</td>
<td colspan="1" rowspan="1">8,067</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">3&nbsp;%</td>
<td colspan="1" rowspan="1">132&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bitcoin Sold</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bitcoin Sales - Net Proceeds</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Average Net Price per Bitcoin Sold</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Deployed Hash Rate - Rockdale 2</td>
<td colspan="1" rowspan="1">15.0 EH/s</td>
<td colspan="1" rowspan="1">15.0 EH/s</td>
<td colspan="1" rowspan="1">12.4 EH/s</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0&nbsp;%</td>
<td colspan="1" rowspan="1">21&nbsp;%</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Deployed Hash Rate - Corsicana 2</td>
<td colspan="1" rowspan="1">15.7 EH/s</td>
<td colspan="1" rowspan="1">15.7 EH/s</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0&nbsp;%</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Deployed Hash Rate - Kentucky 2</td>
<td colspan="1" rowspan="1">2.9 EH/s</td>
<td colspan="1" rowspan="1">2.8 EH/s</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">3&nbsp;%</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Deployed Hash Rate - Total 2</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">33.6 EH/s</td>
<td colspan="1" rowspan="1">33.5 EH/s</td>
<td colspan="1" rowspan="1">12.4 EH/s</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0&nbsp;%</td>
<td colspan="1" rowspan="1">171&nbsp;%</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Avg. Operating Hash Rate - Rockdale 3</td>
<td colspan="1" rowspan="1">12.9 EH/s</td>
<td colspan="1" rowspan="1">12.7 EH/s</td>
<td colspan="1" rowspan="1">8.5 EH/s</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">2&nbsp;%</td>
<td colspan="1" rowspan="1">52&nbsp;%</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Avg. Operating Hash Rate - Corsicana 3</td>
<td colspan="1" rowspan="1">13.9 EH/s</td>
<td colspan="1" rowspan="1">14.2 EH/s</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-2&nbsp;%</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Avg. Operating Hash Rate - Kentucky 3</td>
<td colspan="1" rowspan="1">2.6 EH/s</td>
<td colspan="1" rowspan="1">2.4 EH/s</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">7&nbsp;%</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Avg. Operating Hash Rate - Total 3</td>
<td colspan="1" rowspan="1">29.4 EH/s</td>
<td colspan="1" rowspan="1">29.3 EH/s</td>
<td colspan="1" rowspan="1">8.5 EH/s</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0&nbsp;%</td>
<td colspan="1" rowspan="1">246&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Power Credits 4</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$2.1 million</td>
<td colspan="1" rowspan="1">$3.2 million</td>
<td colspan="1" rowspan="1">$0.7 million</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-36&nbsp;%</td>
<td colspan="1" rowspan="1">180&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Demand Response Credits 5</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$0.7 million</td>
<td colspan="1" rowspan="1">$1.0 million</td>
<td colspan="1" rowspan="1">$0.2 million</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-25&nbsp;%</td>
<td colspan="1" rowspan="1">249&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Power Credits</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$2.8 million</td>
<td colspan="1" rowspan="1">$4.2 million</td>
<td colspan="1" rowspan="1">$1.0 million</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-33&nbsp;%</td>
<td colspan="1" rowspan="1">196&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">All-in Power Cost - Rockdale 6</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">3.5c/kWh</td>
<td colspan="1" rowspan="1">3.4c/kWh</td>
<td colspan="1" rowspan="1">4.0c/kWh</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">4&nbsp;%</td>
<td colspan="1" rowspan="1">-11&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">All-in Power Cost - Corsicana 6</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">3.7c/kWh</td>
<td colspan="1" rowspan="1">3.4c/kWh</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">8&nbsp;%</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="1" rowspan="1">All-in Power Cost - Kentucky 6</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">4.0c/kWh</td>
<td colspan="1" rowspan="1">3.9c/kWh</td>
<td colspan="1" rowspan="1">N/A</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">4&nbsp;%</td>
<td colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td colspan="1" rowspan="1">All-in Power Cost - Total 6</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">3.6c/kWh</td>
<td colspan="1" rowspan="1">3.4c/kWh</td>
<td colspan="1" rowspan="1">4.0c/kWh</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">7&nbsp;%</td>
<td colspan="1" rowspan="1">-8&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fleet Efficiency 2</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">21.0 J/TH</td>
<td colspan="1" rowspan="1">21.1 J/TH</td>
<td colspan="1" rowspan="1">27.0 J/TH</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">-1&nbsp;%</td>
<td colspan="1" rowspan="1">-22&nbsp;%</td>
</tr>
</tbody>
</table>
</figure>
<ol>
<li>Unaudited, estimated.</li>
<li>As of month-end.</li>
<li>Average over the month.</li>
<li>Estimated power curtailment credits.</li>
<li>Estimated credits received from participation in&nbsp;ERCOT and MISO demand response programs.</li>
<li>Estimated. Inclusive of all transmission and distribution charges, fees, adders, and taxes. Net of Total Power Credits.</li>
</ol>

RIOT

Riot Announces February 2025 Production And Operations Updates; 470 Bitcoin Produced; 18,692 Bitcoin Held

FedRAMP Moderate authorization for SailPoint's Non-Employee Risk Management product further demonstrates commitment to maintaining compliance and operational efficiency

SAIL

SailPoint's Non-Employee Risk Management Achieves FedRAMP Authorization

ALMS

SLRN

ACELYRIN Board Determined The Unsolicited Indication Of Interest From Concentra Biosciences Was 'Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger'

Goldman Sachs analyst Mike Harris maintains Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) with a Buy and lowers the price target from $17 to $15.

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Cleveland-Cliffs, Lowers Price Target to $15

The Campbell&#8217;s Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) will release its second-quarter financial results, before the <a href="https://www.benzinga.com/quote/CPB/earnings">opening bell, on Wednesday.</a>
Analysts expect the company to report quarterly earnings at 72 cents per share, down from 80 cents per share in the year-ago period. Campbell&#8217;s projects quarterly revenue of $2.74 billion, compared to $2.46 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 22, The Campbell&#8217;s Company named Risa Cretella as executive vice President and president, Meals &amp; Beverages.
With the recent buzz around Campbell&#8217;s, some investors may be eyeing potential gains from the company's dividends too. As of now, Campbell&#8217;s offers an annual dividend yield of 3.78%, which is a quarterly dividend amount of 39 cents per share ($1.56 a year). &nbsp;
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $158,801 or around 3,846 shares. For a more modest $100 per month or $1,200 per year, you would need $31,752 or around 769 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($1.56 in this case). So, $6,000 / $1.56 = 3,846 ($500 per month), and $1,200 / $1.56 = 769 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
CPB Price Action: Shares of Campbell&#8217;s gained 3.1% to close at $41.29 on Monday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44083539/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo: JHVEPhoto via Shutterstock

Earnings

Long Ideas

How To Earn $500 A Month From Campbell's Stock Ahead Of Q2 Earnings

Biotech

General

CING

Cingulate Reports Reports Safety Results From Final Phase 3 Trials CTx-1301 And Submits Results Ahead Of In-person FDA Meeting Set For Apr. 2; Says No Subjects Have Experienced A Serious Treatment Emergent Adverse Event (TEAE), A Serious TEAE Or A TEAE Leading To Death

Dear Shareholders,
I am happy to take this opportunity to provide our shareholders with an overview of our key accomplishments and outline our future direction.&nbsp;
Oramed-HTIT Joint Venture: OraTech - A Transformational Partnership
We are excited about our joint venture, OraTech Pharmaceuticals, Inc. ("OraTech"), which we believe represents a significant step forward in advancing our proprietary oral drug delivery technology. This company will serve as the foundation for developing, marketing, and commercializing innovative treatments leveraging Oramed's oral insulin and POD&#x2122; platform.
The collaboration combines Oramed's innovative drug delivery technology with Hefei Tianhui Biotech Co., Ltd's ("HTIT") state-of-the-art manufacturing capabilities, creating a powerful synergy that we believe positions OraTech as a true game-changer in the pharmaceutical industry. This integration of cutting-edge technology and advanced manufacturing expertise will enable us to ensure consistent, high-quality production at scale, setting new standards for oral protein delivery.
OraTech is backed by a substantial capital and operational commitment. These resources are earmarked to support the initiation of a Phase 3 clinical trial in the U.S., a key milestone in bringing oral insulin to market. By leveraging insights from prior clinical studies, we have strategically designed this refined Phase 3 trial to focus on key patient subpopulations that we believe have the highest potential to demonstrate efficacy.
In parallel, HTIT has already submitted a Marketing Authorization Application to China's regulators for the oral insulin capsule in China. Commercialization preparations are underway, and OraTech is expected to receive royalties from sales in China.
The establishment of OraTech represents a unique opportunity to build a company focused on advancing next-generation therapies, unlocking new market potential.
Stock Dividend and Strategic Opportunities
OraTech has initiated work on the Securities and Exchange Commission registration process with the goal of achieving Nasdaq trading status later this year. As part of this strategic initiative, Oramed plans to distribute OraTech stock to its shareholders via a dividend, granting them the majority of Oramed's ownership in OraTech. This distribution is expected to coincide with OraTech's public trading debut on Nasdaq.
Cash Dividend
Oramed is evaluating an opportunity to issue cash dividends of approximately $0.25 per share intended to help offset any potential tax liabilities associated with the OraTech stock distribution. Beyond mitigating potential tax concerns, this initiative underscores our commitment to maximizing shareholder value.
Strategic Scilex Financing : Delivering Tangible Value
Our investment in Scilex Holding Company ("Scilex") underscores our commitment to generating meaningful value through well-structured financial transactions. To date, we have received $70 million from our $99.5 million secured loan agreement, with additional payments of approximately $53 million expected over the&nbsp; next two years.
Beyond these direct financial returns, the transaction has provided us with 12.25 million shares of Scilex common stock, which will increase to 18.75 million shares this month as a result of warrant vesting. Additionally, we structured this deal to include meaningful upside through ongoing royalty streams from the following Scilex products:
<ul>
<li>ZTlido – A 4% royalty on sales worldwide for the next decade and a 25% profit share on the majority of sales outside the U.S., leveraging its U.S. Food and Drug Administration approval as a lidocaine topical system targeting the global pain patch market valued at $4.8 billion in 2021, and is projected to reach $7.3 billion by 2031. Oramed will receive $400,000 in royalties for Q4 2024 and expects this amount to increase on a quarterly basis. More details at <a href="https://ztlido.com/">www.ztlido.com</a>.</li>
<li>ELYXYB – The first ready-to-use oral solution for acute migraines, addressing a condition that affects approximately 39 million Americans. We hold a 2% royalty on worldwide sales. More details at <a href="https://www.elyxyb.com/">www.elyxyb.com</a>.</li>
<li>GLOPERBA – An innovative oral liquid formulation for gout treatment, tapping into a market with strong growth potential. We hold a 2% royalty on worldwide sales and a 25% profit share on the majority of sales outside the U.S. More details at <a href="https://www.gloperba.com/">www.gloperba.com</a>.</li>
</ul>
Strong Balance Sheet: Positioned for Growth and Value Creation
Oramed maintains a robust financial position, strengthened by our strategic Scilex transaction and the OraTech joint venture. Our disciplined approach to cash management includes CDs, bonds, real estate and equities. We believe that our disciplined capital allocation strategy enables us to maintain sufficient liquidity for both our core operations and strategic initiatives, positioning Oramed for sustainable long-term growth.
Looking Ahead: A Commitment to Strategic Growth
Looking forward, we are actively pursuing acquisitions and partnerships that leverage our expertise in technology development and strategic dealmaking. We have identified several promising opportunities across multiple innovation ecosystems and expect to announce additional strategic initiatives in the coming quarters.
Sincerely, Nadav Kidron&nbsp; Chief Executive Officer

ORMP

Oramed Pharmaceuticals Issues Letter To Shareholders From President And CEO Nadav Kidron

Macro Economic Events

Econ #s

Economics

U.S. Commerce Secretary Lutnick Says On April 2 We Will See A Reordering And A Renegotiation Of Trade With U.S. Trading Partners Under Reciprocal Tariff Action

In the last three months, 18 analysts have published ratings on Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>), offering a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $117.11, a high estimate of $135.00, and a low estimate of $86.00. Marking an increase of 12.44%, the current average surpasses the previous average price target of $104.15. 
<img src="https://www.benzinga.com/files/images/story/2025/1741096870_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Expand Energy among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$86.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$117.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$133.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Strong Buy</td>
<td>$135.00</td>
<td>-</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$121.00</td>
<td>-</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$113.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Neutral</td>
<td>$96.00</td>
<td>-</td>
</tr>
<tr>
<td>Cameron Bean</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$130.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Paul Diamond</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$125.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Zach Parham</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Overweight</td>
<td>$112.00</td>
<td>-</td>
</tr>
<tr>
<td>Subash Chandra</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$93.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$116.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$133.00</td>
<td>$109.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Overweight</td>
<td>$127.00</td>
<td>-</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$128.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$123.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Paul Diamond</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Expand Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Expand Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Expand Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Expand Energy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EXE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Expand Energy analyst ratings.</a>
<h2>Unveiling the Story Behind Expand Energy</h2>
Expand Energy Corp independent natural gas producer in the United States. It is fueling a more affordable, reliable and lower-carbon future. The group focused on developing abundant natural gas, oil, and gas liquids to expand energy access.
<h3>Key Indicators: Expand Energy's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Expand Energy displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 10.5%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Expand Energy's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -19.96%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Expand Energy's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -2.88%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Expand Energy's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.93%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Expand Energy's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.33.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Expand Energy Through The Eyes Of 18 Analysts

Analysts' ratings for Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) over the last quarter vary from bullish to bearish, as provided by 12 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.42, a high estimate of $26.00, and a low estimate of $19.00. This current average has decreased by 1.68% from the previous average price target of $23.82. 
<img src="https://www.benzinga.com/files/images/story/2025/1741096859_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Albertsons Companies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Leah Jordan</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Buy</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Mark Carden</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$21.00</td>
<td>$27.25</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Albertsons Companies. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Albertsons Companies compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Albertsons Companies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Albertsons Companies's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ACI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Albertsons Companies analyst ratings.</a>
<h2>About Albertsons Companies</h2>
Albertsons is the second largest supermarket operator in the United States with more than 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.
<h3>Albertsons Companies's Financial Performance</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Albertsons Companies's remarkable performance in 3 months is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 1.17%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 2.13%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Albertsons Companies's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 12.55% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Albertsons Companies's ROA excels beyond industry benchmarks, reaching 1.51%. This signifies efficient management of assets and strong financial health.
Debt Management: Albertsons Companies's debt-to-equity ratio surpasses industry norms, standing at 4.22. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Albertsons Companies: Insights From 12 Financial Analysts

Globe Life's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) short percent of float has risen 8.33% since its last report. The company recently reported that it has 1.68 million shares sold short, which is 2.34% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.55 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Globe Life Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741096851_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Globe Life has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Globe Life's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Globe Life's peer group average for short interest as a percentage of float is 2.45%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

What Does the Market Think About Globe Life?

Goldman Sachs analyst David Roman maintains Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with a Buy and raises the price target from $138 to $154.

Goldman Sachs Maintains Buy on Abbott Laboratories, Raises Price Target to $154

Across the recent three months, 9 analysts have shared their insights on Gaming and Leisure Props (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPI#NASDAQ">GLPI</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $53.84, with a high estimate of $56.00 and a low estimate of $49.00. This upward trend is apparent, with the current average reflecting a 0.41% increase from the previous average price target of $53.62.
<img src="https://www.benzinga.com/files/images/story/2025/1741096850_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Gaming and Leisure Props's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$53.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$49.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$53.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$54.53</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Greff</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$49.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Gaming and Leisure Props. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Gaming and Leisure Props compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Gaming and Leisure Props's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Gaming and Leisure Props's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GLPI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Gaming and Leisure Props analyst ratings.</a>
<h2>Discovering Gaming and Leisure Props: A Closer Look</h2>
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.
<h3>Financial Milestones: Gaming and Leisure Props's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Gaming and Leisure Props's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 5.58%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Gaming and Leisure Props's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 55.71%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Gaming and Leisure Props's ROE stands out, surpassing industry averages. With an impressive ROE of 5.09%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Gaming and Leisure Props's ROA stands out, surpassing industry averages. With an impressive ROA of 1.67%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Gaming and Leisure Props's debt-to-equity ratio is below the industry average at 1.88, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GLPI

Assessing Gaming and Leisure Props: Insights From 9 Financial Analysts

For the first time since the Great Recession, banks didn't park a single dollar in <a href="https://www.benzinga.com/topic/federal-reserve">the Federal Reserve</a>'s Reverse Repo Facility overnight. That's right—zero bids. 
The mother ship of the U.S. banking system, which has been the go-to safety net for surplus cash, found no takers.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="580" height="738" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04071824/Screenshot-2025-03-04-at-5.48.00-PM.png" alt="" class="wp-image-807933" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04071824/Screenshot-2025-03-04-at-5.48.00-PM.png 580w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04071824/Screenshot-2025-03-04-at-5.48.00-PM-236x300.png 236w" sizes="(max-width: 580px) 100vw, 580px" /></figure>
Source: <a href="https://www.newyorkfed.org/markets/data-hub">NewYorkFed website</a>
This isn't just an obscure balance sheet event. It's a flashing red warning light that bank liquidity is vanishing — fast.
<h2 class="wp-block-heading">Where Did All The Money Go?</h2>
After COVID stimulus flooded banks with cash, the Reverse Repo Facility ballooned to over $2 trillion in 2022-23. But as inflation eroded savings and delinquency rates climbed, that cash pile has been slowly draining. Now, we may have hit a breaking point.
Banks no longer have excess cash to lend to the Fed. More concerning? 
Interbank lending has already dried up. This suggests financial institutions could soon be forced into net borrowing mode — a signal of growing stress in the system.
<h2 class="wp-block-heading">Market Impact: Bonds, Stocks, What's Next</h2>
The bond market is reacting. Yields on Treasuries longer than two years are dropping fast, signaling investors believe rates have peaked. 
Five-Year Treasury Yield:
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="361" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070329/fredgraph-2-1024x361.png" alt="" class="wp-image-807923" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070329/fredgraph-2-1024x361.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070329/fredgraph-2-300x106.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070329/fredgraph-2-768x271.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070329/fredgraph-2.png 1320w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
10-Year Treasury Yield:
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="361" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070402/fredgraph-3-1024x361.png" alt="" class="wp-image-807924" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070402/fredgraph-3-1024x361.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070402/fredgraph-3-300x106.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070402/fredgraph-3-768x271.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04070402/fredgraph-3.png 1320w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
They're locking in returns now before the next recession resets the game.
This capital shift is also dragging down stocks. Liquidity is the lifeblood of markets, and if banks are running on fumes, risk assets will feel the squeeze.
<h2 class="wp-block-heading">Actionable Plays: Where Investors Can Look Now</h2>
For those watching from the sidelines, here are key ETFs to monitor:
<ul>
<li>For Bond Bulls: If yields keep dropping, bond prices will rise. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) and the iShares 7-10 Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEF#NASDAQ">IEF</a>) are prime plays.</li>
<li>For Stock Protection: If liquidity crunch fears escalate, defensive sectors could shine. The Consumer Staples Select Sector SPDR ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) and Utilities Select Sector SPDR ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) could offer stability.</li>
<li>For Financial Risk: Bank stress is mounting. The SPDR S&amp;P Bank ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBE#NYSE">KBE</a>) and Financial Select Sector SPDR ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) will be key indicators of how this liquidity squeeze plays out.</li>
</ul>
This liquidity drain wasn't a surprise to those paying attention &#8211; but what happens next will be. 
Keep a close eye on the Fed's next moves, because the money spigot may be running dry.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44107516/autozone-q2-earnings-miss-estimates-revenues-grow-24">AutoZone Q2 Earnings: Miss Estimates, 2.4% Revenue Growth, Higher Inventory And More</a></li>
</ul>
Image: Shutterstock

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

Federal Reserve

ETFs

iShares Trust Barclays 7-10 Year Treasury Bond Fund

iShares Trust Barclays 20+ Year Treasury Bond Fund

No Bidders, No Safety Net: Is Fed's Liquidity Lifeline Drying Up? Plus, ETFs To Watch

Samsara's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) short percent of float has risen 10.78% since its last report. The company recently reported that it has 12.08 million shares sold short, which is 5.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.45 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Samsara Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741096843_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Samsara has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Samsara's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Samsara's peer group average for short interest as a percentage of float is 2.90%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Samsara Gaining or Losing Market Support?

During the last three months, 4 analysts shared their evaluations of Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $15.0, along with a high estimate of $15.00 and a low estimate of $15.00. This current average is unchanged from the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2025/1741096840_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Emergent BioSolutions. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Announces</td>
<td>Buy</td>
<td>$15.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Emergent BioSolutions. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Emergent BioSolutions compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Emergent BioSolutions's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Emergent BioSolutions's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EBS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Emergent BioSolutions analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Emergent BioSolutions Better</h2>
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
<h3>Emergent BioSolutions: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Emergent BioSolutions displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 7.5%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 40.45%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Emergent BioSolutions's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 25.66% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 7.68%, the company showcases effective utilization of assets.
Debt Management: Emergent BioSolutions's debt-to-equity ratio surpasses industry norms, standing at 1.3. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Emergent BioSolutions Stands With Analysts

Stride's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) short percent of float has fallen 4.68% since its last report. The company recently reported that it has 4.52 million shares sold short, which is 14.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.17 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Stride Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741096838_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Stride has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Stride's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Stride's peer group average for short interest as a percentage of float is 3.79%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Stride Gaining or Losing Market Support?

VICI Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $34.4, a high estimate of $36.00, and a low estimate of $30.00. This current average has decreased by 2.24% from the previous average price target of $35.19. 
<img src="https://www.benzinga.com/files/images/story/2025/1741096828_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive VICI Props is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$34.00</td>
<td>$33.75</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$35.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$36.00</td>
<td>-</td>
</tr>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$30.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$33.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to VICI Props. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of VICI Props compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for VICI Props's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of VICI Props's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/VICI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on VICI Props analyst ratings.</a>
<h2>Get to Know VICI Props Better</h2>
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.
<h3>Financial Milestones: VICI Props's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: VICI Props's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 4.74%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: VICI Props's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 62.97% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.33%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.36%, the company showcases effective utilization of assets.
Debt Management: VICI Props's debt-to-equity ratio is below the industry average. With a ratio of 0.67, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VICI

Deep Dive Into VICI Props Stock: Analyst Perspectives (10 Ratings)

Press Releases

Zenvia Files its Annual Report on Form 20-F for Fiscal Year 2023

Zenvia unveils its cutting-edge Generative AI Chatbot solution, revolutionizing the interaction landscape between brands and consumers

ZENVIA Reports Q1 2024 Results

ZENVIA sets agenda for fiscal second quarter and first half 2024 results

ZENVIA Reports Q2 2024 and H1 2024 Results

Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences

ZENVIA sets agenda for fiscal third quarter and first nine months 2024 results

ZENVIA Reports Q3 2024 and 9M 2024 Results

Fintech

Zenvia Announces New Strategic Cycle

Zenvia announces Conference Call on New Strategic Cycle

ACCESS Newswire

AudioEye

ReAlpha Tech

XIAO-I Corporation - American Depositary Shares

XIAO-I

Aware

BTCS

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares

Comments

Zenvia

Noticias

Últimas noticias sobre Zenvia (NASDAQ:ZENV) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL